| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica
|
Robilliard, Bertrand
|
|
|
103 |
C |
p. 281-283
|
artikel
|
| 2 |
Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology
|
Cabarrou, Bastien
|
|
|
103 |
C |
p. 120-126
|
artikel
|
| 3 |
Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2–positive breast cancer
|
van Rooijen, Johan M.
|
|
|
103 |
C |
p. 52-60
|
artikel
|
| 4 |
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours
|
Arkenau, H.-T.
|
|
|
103 |
C |
p. 17-23
|
artikel
|
| 5 |
Avoidable cancers in the Nordic countries—The impact of alcohol consumption
|
Andersson, Therese M-L.
|
|
|
103 |
C |
p. 299-307
|
artikel
|
| 6 |
Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy
|
Panariello, Luigia
|
|
|
103 |
C |
p. 284-286
|
artikel
|
| 7 |
Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2
|
Campone, Mario
|
|
|
103 |
C |
p. 147-154
|
artikel
|
| 8 |
Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century
|
Calvo, Fabien
|
|
|
103 |
C |
p. 155-159
|
artikel
|
| 9 |
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
|
Ferlay, J.
|
|
|
103 |
C |
p. 356-387
|
artikel
|
| 10 |
Cardiac safety evaluation in cancer clinical trials
|
Gujral, Dorothy M.
|
|
|
103 |
C |
p. 143-146
|
artikel
|
| 11 |
Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer
|
Allin, D.M.
|
|
|
103 |
C |
p. 165-175
|
artikel
|
| 12 |
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database
|
Salem, Mohamed E.
|
|
|
103 |
C |
p. 205-213
|
artikel
|
| 13 |
Corrigendum to ‘Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update’ [Eur J Cancer 94 (May 2018) 115–125]
|
Choueiri, Toni K.
|
|
|
103 |
C |
p. 287
|
artikel
|
| 14 |
Environment, cancer and inequalities—The urgent need for prevention
|
Vineis, Paolo
|
|
|
103 |
C |
p. 317-326
|
artikel
|
| 15 |
Factors influencing treatment selection and 30-day mortality after chemotherapy for people with small-cell lung cancer: An analysis of national audit data
|
Jones, Gavin S.
|
|
|
103 |
C |
p. 176-183
|
artikel
|
| 16 |
Familial risk of pleural mesothelioma increased drastically in certain occupations: A nationwide prospective cohort study
|
Kharazmi, Elham
|
|
|
103 |
C |
p. 1-6
|
artikel
|
| 17 |
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study)
|
Kim, Ji-Yeon
|
|
|
103 |
C |
p. 127-136
|
artikel
|
| 18 |
Haematological toxicities with immunotherapy in patients with cancer: a systematic review and meta-analysis
|
Petrelli, Fausto
|
|
|
103 |
C |
p. 7-16
|
artikel
|
| 19 |
How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma
|
Steeb, Theresa
|
|
|
103 |
C |
p. 41-51
|
artikel
|
| 20 |
Human papillomavirus–associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications
|
Lu, Diana J.
|
|
|
103 |
C |
p. 195-204
|
artikel
|
| 21 |
Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?
|
Prud'homme, Clara
|
|
|
103 |
C |
p. 108-119
|
artikel
|
| 22 |
Letter comments on EJC published article: Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2–positive breast carcinomatous meningitis
|
Hofer, Silvia
|
|
|
103 |
C |
p. 279-280
|
artikel
|
| 23 |
Monitoring potentially modifiable lifestyle factors in cancer survivors: A narrative review on currently available methodologies and innovations for large-scale surveillance
|
Derksen, Jeroen W.G.
|
|
|
103 |
C |
p. 327-340
|
artikel
|
| 24 |
Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey
|
Paillaud, E.
|
|
|
103 |
C |
p. 61-68
|
artikel
|
| 25 |
Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours
|
Mir, Olivier
|
|
|
103 |
C |
p. 88-97
|
artikel
|
| 26 |
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents
|
Byrne, Julianne
|
|
|
103 |
C |
p. 227-237
|
artikel
|
| 27 |
Patient-assisted compression helps for image quality reduction dose and improves patient experience in mammography
|
Balleyguier, Corinne
|
|
|
103 |
C |
p. 137-142
|
artikel
|
| 28 |
Prevalence of beliefs about actual and mythical causes of cancer and their association with socio-demographic and health-related characteristics: Findings from a cross-sectional survey in England
|
Shahab, Lion
|
|
|
103 |
C |
p. 308-316
|
artikel
|
| 29 |
Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis
|
ter Veer, Emil
|
|
|
103 |
C |
p. 214-226
|
artikel
|
| 30 |
Relation between mortality trends of cardiovascular diseases and selected cancers in the European Union, in 1970–2017. Focus on cohort and period effects
|
Malvezzi, M.
|
|
|
103 |
C |
p. 341-355
|
artikel
|
| 31 |
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
|
Nutting, Christopher M.
|
|
|
103 |
C |
p. 249-258
|
artikel
|
| 32 |
Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 ‘Best of’ and 24954 ‘larynx preservation’ study
|
Simon, Christian
|
|
|
103 |
C |
p. 69-77
|
artikel
|
| 33 |
Survival benefit, disease progression and quality-of-life outcomes of abiraterone acetate plus prednisone versus docetaxel in metastatic hormone-sensitive prostate cancer: A network meta-analysis
|
Feyerabend, Susan
|
|
|
103 |
C |
p. 78-87
|
artikel
|
| 34 |
Tackling the tobacco epidemic in the Nordic countries and lower cancer incidence by 1/5 in a 30-year period—The effect of envisaged scenarios changing smoking prevalence
|
Andersson, Therese M.-L.
|
|
|
103 |
C |
p. 288-298
|
artikel
|
| 35 |
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies
|
Simonsen, Katy L.
|
|
|
103 |
C |
p. 259-266
|
artikel
|
| 36 |
The impact of effective systemic therapies on surgery for stage IV melanoma
|
Smith, M.J.F.
|
|
|
103 |
C |
p. 24-31
|
artikel
|
| 37 |
The nephrotoxicity of immune checkpoint inhibitor–based combinations
|
El Rassy, Elie
|
|
|
103 |
C |
p. 274-278
|
artikel
|
| 38 |
The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer
|
Byrne, Julianne
|
|
|
103 |
C |
p. 238-248
|
artikel
|
| 39 |
The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer
|
Gootjes, Elske C.
|
|
|
103 |
C |
p. 160-164
|
artikel
|
| 40 |
Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go?
|
Lim, Chor-Kuan
|
|
|
103 |
C |
p. 32-40
|
artikel
|
| 41 |
UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer
|
Campone, Mario
|
|
|
103 |
C |
p. 184-194
|
artikel
|
| 42 |
Uptake of the English Bowel (Colorectal) Cancer Screening Programme: an update 5 years after the full roll-out
|
Hirst, Yasemin
|
|
|
103 |
C |
p. 267-273
|
artikel
|
| 43 |
Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour
|
Hamada, Tsuyoshi
|
|
|
103 |
C |
p. 98-107
|
artikel
|
Tijdschrift beschrijving